Loading AYTU charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading AYTU comparable companies…
| AYTUAytu Biopharma, Inc.(opens in a new tab) | — | $0.06B | −13.3% | 64.0% | −14.4% | — | — |
|---|---|---|---|---|---|---|---|
| RCUSArcus Biosciences, Inc.(opens in a new tab) | $2.29B | $0.06B | +23.9% | — | −852.6% | 40.20× | — |
| NKTRNektar Therapeutics(opens in a new tab) | $1.28B | $0.05B | −27.2% | 100.0% | −257.8% | 23.53× | — |
| PRTAProthena Corp. Public Ltd Co.(opens in a new tab) | $0.44B | $0.05B | +427.3% | — | −101.8% | 8.10× | — |
| AQSTAquestive Therapeutics, Inc.(opens in a new tab) | $0.49B | $0.05B | +22.6% | 67.0% | −97.5% | 9.02× | — |
| Medianpeers, excl. AYTU | $0.89B | $0.05B | +23.2% | 83.5% | −179.8% | 16.28× | — |